Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P I Karakiewicz

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Der Urologe. Ausg. A|May 17, 2003
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]M Graefen, H Augustin, P I Karakiewicz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 16, 2011
Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: a population-based studyL Budäus, M Morgan, F Abdollah, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2017
Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancerP Dell'Oglio, E Zaffuto, K Boehm, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 29, 2015
Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomyJ Schiffmann, A Haese, Sami-Ramzi Leyh-Bannurah, et al.
ESMO Open|October 8, 2022
The current role of precision surgery in oligometastatic prostate cancerM von Deimling, P Rajwa, D Tilki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2014
The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" periodG Gandaglia, Q-D Trinh, J C Hu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2008
Partin Tables cannot accurately predict the pathological stage at radical prostatectomyN Bhojani, S Ahyai, M Graefen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2014
Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancerA Larcher, M Sun, J Schiffmann, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 17, 2022
Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer PatientsR S Flammia, D Lavigne, Z Tian, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Der Urologe. Ausg. A|May 17, 2003
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]M Graefen, H Augustin, P I Karakiewicz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 16, 2011
Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: a population-based studyL Budäus, M Morgan, F Abdollah, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2017
Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancerP Dell'Oglio, E Zaffuto, K Boehm, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 29, 2015
Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomyJ Schiffmann, A Haese, Sami-Ramzi Leyh-Bannurah, et al.
ESMO Open|October 8, 2022
The current role of precision surgery in oligometastatic prostate cancerM von Deimling, P Rajwa, D Tilki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2014
The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" periodG Gandaglia, Q-D Trinh, J C Hu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2008
Partin Tables cannot accurately predict the pathological stage at radical prostatectomyN Bhojani, S Ahyai, M Graefen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2014
Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancerA Larcher, M Sun, J Schiffmann, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 17, 2022
Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer PatientsR S Flammia, D Lavigne, Z Tian, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
Pageof 5